United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
Go back to United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®| Medtronic Inc. (NYSE: MDT) | Delayed: 94.17 +1.07 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.10 | 52 Week High | $89.27 | |||
| Open | $92.76 | 52 Week Low | $71.03 | |||
| Day High | $94.74 | P/E | 26.75 | |||
| Day Low | $92.31 | EPS | $3.52 | |||
| Volume | 9,013,903 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 487.61 -2.63 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $490.24 | 52 Week High | $164.04 | |||
| Open | $484.33 | 52 Week Low | $97.52 | |||
| Day High | $494.09 | P/E | 89.14 | |||
| Day Low | $484.33 | EPS | $5.47 | |||
| Volume | 327,025 | |||||
